American Century Companies’s Integra LifeSciences IART Stock Holding History

American Century Companies’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.64M	Buy	147,084 +19,442	+15%	+$272K	﹤0.01%	2114
2026 Q1	$1.2M	Buy	127,642 +8,736	+7%	+$95.9K	﹤0.01%	2273
2025 Q4	$1.48M	Buy	118,906 +7,312	+7%	+$97.2K	﹤0.01%	2199
2025 Q3	$1.6M	Sell	111,594 -161,771	-59%	-$2.22M	﹤0.01%	2153
2025 Q2	$3.35M	Sell	273,365 -300,572	-52%	-$4.36M	﹤0.01%	1840
2025 Q1	$12.6M	Buy	573,937 +392,454	+216%	+$9.23M	0.01%	1237
2024 Q4	$4.12M	Buy	181,483 +122,317	+207%	+$2.67M	﹤0.01%	1681
2024 Q3	$1.08M	Sell	59,166 -21,141	-26%	-$490K	﹤0.01%	2210
2024 Q2	$2.34M	Buy	80,307 +6,586	+9%	+$195K	﹤0.01%	1850
2024 Q1	$2.61M	Buy	73,721 +60,785	+470%	+$2.43M	﹤0.01%	1769
2023 Q4	$563K	Hold	12,936	–	–	﹤0.01%	2325
2023 Q3	$494K	Buy	12,936 +224	+2%	+$9.42K	﹤0.01%	2273
2023 Q2	$523K	Buy	12,712 +198	+2%	+$9.53K	﹤0.01%	2202
2023 Q1	$707K	Buy	12,514 +3,351	+37%	+$189K	﹤0.01%	2004
2022 Q4	$514K	Buy	9,163 +1,940	+27%	+$98.7K	﹤0.01%	2039
2022 Q3	$306K	Buy	7,223 +2,726	+61%	+$140K	﹤0.01%	2102
2022 Q2	$243K	Sell	4,497 -6,223	-58%	-$374K	﹤0.01%	2100
2022 Q1	$689K	Buy	+10,720	New	+$706K	﹤0.01%	1821
2021 Q1	–	Sell	-6,066	Closed	-$394K	–	2221
2020 Q4	$394K	Hold	6,066	–	–	﹤0.01%	1646
2020 Q3	$286K	Sell	6,066 -88	-1%	-$4.19K	﹤0.01%	1569
2020 Q2	$289K	Sell	6,154 -282	-4%	-$13.9K	﹤0.01%	1466
2020 Q1	$287K	Buy	+6,436	New	+$338K	﹤0.01%	1323
2017 Q3	–	Sell	-51,638	Closed	-$2.81M	–	1353
2017 Q2	$2.81M	Sell	51,638 -145,192	-74%	-$6.93M	﹤0.01%	980
2017 Q1	$8.29M	Buy	196,830 +5,658	+3%	+$242K	0.01%	724
2016 Q4	$8.2M	Buy	191,172 +97,904	+105%	+$3.98M	0.01%	716
2016 Q3	$3.85M	Sell	93,268 -116,526	-56%	-$4.88M	﹤0.01%	946
2016 Q2	$8.37M	Sell	209,794 -28,156	-12%	-$1.01M	0.01%	693
2016 Q1	$8.01M	Buy	237,950 +8,746	+4%	+$272K	0.01%	697
2015 Q4	$7.77M	Buy	229,204 +4,326	+2%	+$135K	0.01%	695
2015 Q3	$6.7M	Buy	224,878 +153,346	+214%	+$4.79M	0.01%	735
2015 Q2	$1.97M	Buy	+71,532	New	+$1.91M	﹤0.01%	1027
2015 Q1	–	Sell	-273,726	Closed	-$6.07M	–	1396
2014 Q4	$6.07M	Sell	273,726 -3,670	-1%	-$74.4K	0.01%	812
2014 Q3	$5.63M	Sell	277,396 -10,326	-4%	-$206K	0.01%	832
2014 Q2	$5.54M	Hold	287,722	–	–	0.01%	859
2014 Q1	$5.41M	Buy	287,722 +16,443	+6%	+$317K	0.01%	887
2013 Q4	$5.29M	Sell	271,279 -82,532	-23%	-$1.51M	0.01%	885
2013 Q3	$5.82M	Sell	353,811 -32,714	-8%	-$525K	0.01%	839
2013 Q2	$5.79M	Buy	+386,525	New	+$5.66M	0.01%	811

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

American Century Companies's IART Position: Q2 2026 in Review

American Century Companies increased its Integra LifeSciences (IART) stake by 15% in Q2 2026, buying an estimated $272K and bringing the position to 147,084 shares worth $2.64M. The position accounts for ﹤0.01% of the portfolio, ranked #2114.

American Century Companies first reported a position in IART in Q2 2013 and has held it in 38 quarters since. The position peaked at $12.6M in Q1 2025. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

American Century Companies held 147,084 shares of Integra LifeSciences worth $2.64M as of Q2 2026.
American Century Companies bought 19,442 Integra LifeSciences shares in Q2 2026, an estimated $272K.
Integra LifeSciences made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2114 holding.
American Century Companies first reported a position in Integra LifeSciences in Q2 2013 and has held it in 38 quarters since.
American Century Companies's Integra LifeSciences position peaked at $12.6M in Q1 2025.
213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.